Unity Biotechnology, Inc. (UBX) Social Stream



Unity Biotechnology, Inc. (UBX): $1.92

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

B

Add UBX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#55 of 345

in industry

UNITY BIOTECHNOLOGY INC (UBX) Price Targets From Analysts

Use the tables below to see what analysts covering UNITY BIOTECHNOLOGY INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-05 6 $12 $4 $7.8 $2.02 286.14%
2021-11-12 6 $12 $4 $7.666 $2.02 279.5%
2021-12-15 7 $12 $4 $7.142 $2.02 253.56%
2022-05-12 7 $12 $3 $7 $2.02 246.53%
2022-05-17 5 $12 $3 $6.857 $2.02 239.46%
2022-08-15 6 $12 $3 $6.857 $2.02 239.46%
2022-08-16 6 $12 $3 $7.428 $2.02 267.72%
2022-10-13 6 $120 $30 $78.333 $2.02 3777.87%
2022-10-20 6 $120 $11 $75.166 $2.02 3621.09%
2022-11-02 6 $120 $11 $74.5 $2.02 3588.12%
2022-11-10 6 $120 $10 $56 $2.02 2672.28%
2022-11-11 6 $80 $10 $38 $2.02 1781.19%
2022-11-16 6 $80 $10 $26.666 $2.02 1220.1%
2023-03-20 5 $80 $10 $29.8 $2.02 1375.25%
2023-04-05 5 $12 $5 $7.6 $2.02 276.24%
2023-05-15 5 $12 $3 $7.2 $2.02 256.44%
2023-05-26 5 $12 $3 $7.4 $2.02 266.34%
2023-05-31 6 $12 $3 $7.833 $2.02 287.77%
2023-06-26 6 $10 $2 $6.8 $2.02 236.63%
2023-07-10 6 $12.001 $2 $7.666 $2.02 279.5%
2023-08-11 6 $12 $2 $7.666 $2.02 279.5%
2023-08-31 6 $10 $2 $7.333 $2.02 263.02%
2023-11-14 5 $10 $2 $6.8 $2.02 236.63%
2023-11-16 4 $10 $4 $6.5 $2.02 221.78%

The Trend in the Analyst Price Target


UBX's average price target has moved down $0.64 over the prior 20 months.

Over the past 39 weeks, UBX's average upside potential has been 280.62%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-05-10 5 12.000 3 7.200 2.88 150%
2023-05-12 5 12.000 3 7.200 2.68 168.66%
2023-05-26 5 12.000 3 7.400 2.92 153.42%
2023-07-10 6 12.001 2 7.666 3.10 147.29%
2023-07-11 6 12.000 2 7.666 3.08 148.9%

UBX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


Over the past 31 weeks, UBX's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for UBX as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, UNITY BIOTECHNOLOGY INC's variance in analysts' estimates is lower than -2601.16% of them.
  • UNITY BIOTECHNOLOGY INC's upside potential (average analyst target price relative to current price) is greater than 2618.11% of all US stocks.
  • UNITY BIOTECHNOLOGY INC's average analyst price target is greater than 556.81% of all US stocks.
  • In the context of stocks in the small market cap category, UNITY BIOTECHNOLOGY INC's number of analysts covering the stock is higher than 1968.67% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to UNITY BIOTECHNOLOGY INC are FIXX, BTAI, and IFRX.

Is UBX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!